Expected Orders Upon Admission for C. difficile Infection
Upon admission with suspected C. difficile infection, expect immediate stool testing using a two-step diagnostic algorithm, contact isolation precautions, discontinuation of non-essential antibiotics, and empiric oral vancomycin 125 mg four times daily if severe disease is suspected. 1, 2
Diagnostic Testing Orders
Stool specimen collection and testing should be ordered immediately for patients with ≥3 unformed stools in 24 hours. 1, 2 The recommended approach is a two-step algorithm: either GDH screening followed by toxin testing, or NAAT (PCR) followed by toxin confirmation, which balances sensitivity (91%) and specificity (98%) while avoiding false positives from asymptomatic colonization. 3, 2
- Single toxin EIA alone is not recommended due to insufficient sensitivity (70-80%). 3, 2
- Testing should only be performed on unformed stool samples—testing formed stool leads to false positives and unnecessary treatment. 3, 4
- In patients with suspected severe CDI complicated by ileus who cannot produce stool, perirectal swabs can be used with PCR testing (95.7% sensitivity, 100% specificity). 4
- Do not order repeat testing if initial test is negative unless clinical suspicion remains extremely high—repeat stool testing has minimal added value. 5
Laboratory Studies
Complete blood count with differential should be ordered to assess for leukocytosis, which is a marker of severe disease. 6 White blood cell counts can reach leukemoid ranges (≥15,000/mm³ defines severe disease). 7, 6
Comprehensive metabolic panel to evaluate for:
- Hypoalbuminemia (often overlooked marker of severe disease) 6
- Electrolyte disturbances including hypokalemia and hypomagnesemia 2
- Acute kidney injury from dehydration 2
Infection Control Orders
Contact isolation precautions must be implemented immediately upon suspicion, before test results return. 2
Soap and water handwashing orders for all healthcare workers—alcohol-based sanitizers do not inactivate C. difficile spores, and mechanical removal through friction and running water is the only effective method. 1
Medication Orders
Discontinue causative antibiotics if clinically feasible, as continued antibiotic use significantly increases recurrence risk. 1, 2
Treatment Based on Severity:
For mild-to-moderate CDI:
- Oral metronidazole 500 mg three times daily for 10 days 3, 2
- OR oral vancomycin 125 mg four times daily for 10 days (preferred if intolerant to metronidazole) 3
For severe CDI (≥10 unformed stools/day OR WBC ≥15,000/mm³):
For severe-complicated CDI (hypotension, ileus, megacolon):
- Oral vancomycin 125-500 mg four times daily 3
- PLUS vancomycin per rectum 500 mg in 500 mL saline as enema four times daily 3
- AND/OR metronidazole 500 mg IV every 8 hours 3
Empiric therapy should be started immediately if high suspicion of severe CDI exists, even before test results. 3, 2
Contraindicated Orders
Absolutely do NOT order antiperistaltic agents (loperamide, diphenoxylate) as they worsen disease severity, mask symptoms, and precipitate toxic megacolon by trapping toxins against the colonic wall. 1
- If symptomatic management is needed, opioids or octreotide can be used as alternatives. 1
Additional Considerations
Proton pump inhibitors should be discontinued if possible, as they increase recurrence risk. 3
Imaging orders (CT abdomen/pelvis) may be needed if severe disease is suspected with ileus, toxic megacolon, or peritoneal signs. 6
Endoscopy is reserved for cases with extremely high clinical suspicion but persistently negative stool tests, or when immediate diagnosis is critical—it has only 51-55% sensitivity for CDAD but can visualize pseudomembranes. 8, 9, 6
Do NOT order "test of cure" after treatment completion, as patients may shed spores for up to 6 weeks after successful treatment. 3, 2
Common Pitfalls to Avoid
- Testing asymptomatic patients detects colonization rather than infection—only test symptomatic patients with diarrhea. 2, 4, 8
- Ordering multiple repeat tests when initial testing is negative adds minimal value unless clinical suspicion remains extremely high. 5
- Continuing slow-release oral medications during active diarrhea—rapid transit time prevents adequate absorption. 2
- Failing to monitor electrolytes in severe disease—hypomagnesemia and hypokalemia worsen outcomes and contribute to toxic megacolon. 2